The Norwegian Pharmaceuticals in Dosage Market has shown considerable fluctuations over the past decade. Between 2012 and 2016, the market experienced minor ups and downs, peaking in 2014 and troughing in 2015. From 2017 onward, there was a more pronounced upward trend with values generally increasing, peaking in 2021 with a 6.1392 billion USD value. The market saw a slight decline in 2022, closing with a value of 5.8956 billion USD. The average annual growth rate (CAGR) over the last five years has been somewhat erratic, but remained in the positive territory, albeit modestly at 0.38% in the most recent period.
Future trends to watch for include advances in biopharmaceuticals, personalized medicine, and potential regulatory changes which could drive significant growth in the coming years. Monitoring the effects of global supply chain adjustments and local market adaptations will also be crucial for stakeholders.
| # | 59 Countries | US Dollars | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 Germany | 110,040,000,000 | 2023 | -0.57% | +2.9% | View data |
| 2 | 2 Japan | 102,270,000,000 | 2023 | +1.29% | +1.27% | View data |
| 3 | 3 Italy | 90,420,000,000 | 2023 | -0.45% | +3.03% | View data |
| 4 | 4 France | 70,241,000,000 | 2023 | -2.11% | -1.64% | View data |
| 5 | 5 United Kingdom | 69,574,000,000 | 2023 | -0.43% | -2.13% | View data |
| 18 | 18 Vietnam | 6,321,600,000 | 2023 | +4.48% | +4.47% | View data |
| 19 | 19 Portugal | 6,033,800,000 | 2023 | -2.53% | -4.53% | View data |
| 20 | 20 Norway | 5,951,900,000 | 2023 | +1.05% | -0.35% | |
| 21 | 21 Philippines | 5,089,200,000 | 2023 | +3.36% | +4.1% | View data |
| 22 | 22 Finland | 4,941,000,000 | 2023 | -2.53% | -2.14% | View data |
